HIV prevention drug hailed as breakthrough, but who gets access?

3 weeks ago

A medicine injected just twice a year could transform the fight against HIV.

In a 2024 clinical trial involving more than 2,000 young women in South Africa and Uganda, no participants who received lenacapavir contracted HIV.

Recommended Stories